The relevant regulatory authorities have formally approved Reverdia, the joint venture between Royal DSM and Roquette Frères. Reverdia aims to build on its emerging leadership position for bio-based succinic acid through its proprietary production technology and by ensuring reliable supply to meet the evolving market demands. Bio-based succinic acid is a building block that can be used in the manufacture of polymers, resins and many other products.
The facility, scheduled to be operational by the end of Q3, 2012 will have a capacity of about 10kt and is located on the Roquette site in Cassano Spinola, Italy.
